| OVID THERAPEUTICS DL-,001 |
| USA |
| Gesundheit |
| US6904691010 / A2DQ8S |
| 1OT (Frankfurt) / OVID (NASDAQ) |
| FRA:1OT, ETR:1OT, 1OT:GR, NASDAQ:OVID |
| - |
| https://ovidrx.com/ |
|
Ovid Therapeutics Inc. is a biopharmaceutical company focused on developing small molecule medicines for brain conditions characterized by excess neural excitability, such as rare neurological disorders, epilepsies, and seizure-related issues. The co..
>Volltext.. |
| 382.43 Mio. EUR |
| 259.08 Mio. EUR |
| 6.26 Mio. EUR |
| -41.81 Mio. EUR |
| -21.25 Mio. EUR |
| -0.21 EUR |
| 11.49 Mio. EUR |
| 82.72 Mio. EUR |
| -36.89 Mio. EUR |
| 9.88 |
| 1116.93% |
| 9.39% |
| - |
| - |
| - |
| - |
| OVID THERAPEUTICS, OVID THERAPEUTIC, OVID THERA |
| 28.07.26 |
|